<DOC>
	<DOCNO>NCT00681148</DOCNO>
	<brief_summary>The purpose study see botox injection prostate seed implantation ( brachytherapy ) prostate cancer ) improve urinary symptom avoids need urinary tract instrumentation 6-8 month post-operative period one want avoid manipulate radioactive seed , b ) speed drop PSA . Patients randomize botox v saline injection , completion seed implantation procedure .</brief_summary>
	<brief_title>Botulinum Toxin Injection With Prostate Brachytherapy</brief_title>
	<detailed_description>Brachytherapy popular treatment modality localize prostate cancer , radioactive seed implant 18 gauge needle prostate via perineal template rectal ultrasound guidance . The radioactivity deliver several month , depend isotope use . During time , exacerbation urinary voiding symptom early edema prostate gland due implantation procedure , later inflammatory reaction radiation . Because initial acute inflammation may persist many month despite steadily decline dos radiation , attempt make minimize urinary symptom prior brachytherapy pharmacologic therapy ( alpha-blocker ) minimally invasive surgical therapy ( transurethral incision limit transurethral resection avoid significant distortion prostate parenchyma future seed implantation ) . Even precaution , around 30-40 % brachytherapy patient still develop void symptom . With bothersome symptom , intervention defer least 8-10 month avoid distort planned field radiation . Once symptoms develop , various additional pharmacologic measure employ , increased dos alpha-blocker , medrol steroid taper , non-steroidal anti-inflammatory agent . Some patient require intermittent self-catheterization suprapubic catheter urinary diversion . Botulinum toxin use cosmetic us , successfully use treatment overactive bladder , external sphincter dyssynergia , benign prostatic hyperplasia ( BPH ) . The study BPH show reduction symptom score , PSA , prostate volume , latter atrophy due denervation effect . The response last 6-9 month . We propose study botox intraprostatic injection brachytherapy see whether improves urinary symptom avoids need urinary tract instrumentation 6-8 month post-operative period one want avoid manipulate radioactive seed . We also monitor PSA , see measurable augmentation PSA decline botox + Brachytherapy v Brachytherapy alone . We randomize patient botox ( 100 unit &lt; 30 cc prostate ; 200 unit &gt; 30 cc prostate ) v saline injection , administer 2 transperineal injection lateral lobe prostate ( 25-50 mg per injection ) , 5-10 mm proximal bladder neck . Study design : N= 60 ( 30 receive Botox , 30 receive saline ) Followup : AUA Symptoms score weekly 4 week , monthly thereafter Medications urinary symptom Need catheterization PSA check 1 mo , 3 mo , 6 mo , 9 mo , 1 year , 15 mo , 18 mo , 24 mo</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Biopsy proven prostate cancer undergoing brachytherapy Prior allergic reaction botulinum toxin</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Prostate specific antigen ( PSA )</keyword>
	<keyword>Prostate cancer</keyword>
	<keyword>Lower urinary tract symptom</keyword>
	<keyword>Radioactive seed implantation</keyword>
</DOC>